MediciNova, Inc. (NASDAQ:MNOV) Receives $8.33 Consensus PT from Analysts
Shares of MediciNova, Inc. (NASDAQ:MNOV – Get Free Report) have received a consensus rating of “Moderate Buy” from the seven brokerages that are covering the company, Marketbeat Ratings reports. One research analyst has rated the stock with a sell recommendation, one has given a hold recommendation, three have given a buy recommendation and two have […]
19 Sep 03:14 · The Cerbat Gem